"Dobutamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A catecholamine derivative with specificity for BETA-1 ADRENERGIC RECEPTORS. It is commonly used as a cardiotonic agent after CARDIAC SURGERY and during DOBUTAMINE STRESS ECHOCARDIOGRAPHY.
| Descriptor ID |
D004280
|
| MeSH Number(s) |
D02.092.311.220 D02.092.471.683.410
|
| Concept/Terms |
Dobutamine Tartrate- Dobutamine Tartrate
- Tartrate, Dobutamine
- Dobutamine Tartrate (1:1), (S-(R*,R*))-Isomer
|
Below are MeSH descriptors whose meaning is more general than "Dobutamine".
Below are MeSH descriptors whose meaning is more specific than "Dobutamine".
This graph shows the total number of publications written about "Dobutamine" by people in this website by year, and whether "Dobutamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 3 | 0 | 3 |
| 1997 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 1 | 2 |
| 2000 | 1 | 1 | 2 |
| 2001 | 2 | 3 | 5 |
| 2002 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 2 | 2 |
| 2011 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 4 | 4 |
| 2022 | 0 | 1 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dobutamine" by people in Profiles.
-
Clinical Interventions and Hemodynamic Monitoring in the Setting of Left Ventricular Systolic Heart Failure in Children: Insights From a Physiologic Simulator. Am J Ther. 2024 Sep-Oct 01; 31(5):e531-e540.
-
Aortic Valve Calcium Score in Addition to Dobutamine Stress Echocardiography for Low-Flow, Low-Gradient Aortic Stenosis Assessment. J Am Soc Echocardiogr. 2023 12; 36(12):1324-1326.
-
Milrinone or dobutamine in patients with heart failure: evidence from meta-analysis. ESC Heart Fail. 2022 06; 9(3):2049-2050.
-
Dobutamine stress cardiac MRI is safe and feasible in pediatric patients with anomalous aortic origin of a coronary artery (AAOCA). Int J Cardiol. 2021 Jul 01; 334:42-48.
-
Efficacy and safety of levosimendan and dobutamine in heart failure: A systematic review and meta-analysis. Cardiol J. 2021; 28(3):492-493.
-
Levosimendan or dobutamine in patients with low cardiac output syndrome: Results from meta-analysis. Int J Cardiol. 2021 06 15; 333:145.
-
Aortic acceleration as a noninvasive index of left ventricular contractility in the mouse. Sci Rep. 2021 01 12; 11(1):536.
-
Survival With Continuous Outpatient Intravenous Inotrope Therapy in the Modern Era. Am J Ther. 2020 Oct 01; 28(6):e621-e630.
-
The significance of electrocardiographic changes without echocardiographic evidence of segmental wall motion abnormalities in patients undergoing dobutamine stress echocardiography. J Electrocardiol. 2020 Nov - Dec; 63:164-166.
-
Chronic loss of inhibitor-1 diminishes cardiac RyR2 phosphorylation despite exaggerated CaMKII activity. Naunyn Schmiedebergs Arch Pharmacol. 2017 Aug; 390(8):857-862.